GLAXOSMITHKLINE PLC-SPON ADR

GSK stock holders 13F

3 superinvestors reported owning GSK (ADR) according to the gurus' 2018 Q2 reports.

Top 3 gurus who own (GSK) GLAXOSMITHKLINE PLC-SPON ADR

The 3 super investors (holders) owning GSK (by the percentage (%) of portfolio) are Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (7.93%), B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (0.24%) and Sarah Ketterer - Causeway Capital Management (0.17%) as of their 2018 Q2 reports.

To check the latest activities of the top GSK shareholders between value investors, please click on the "Activity" tab.

To see the historical data of GSK's holders please click on the "2018 Q2" dropdown menu and select the date.

# of holders: 3

Period: 2018 Q2

Type: ADR

History

% change to
Portfolio

B. Tweedy, Ch. Browne

Tweedy, Browne Co All Funds (US)

0.24%

155,204

$50.39

$7,820,000

-0.05% (-70)

-0.00%

Sarah Ketterer

Causeway Capital Management

0.17%

342,821

$50.39

$17,274,000

-53.46% (-393,801)

-0.20%

Thomas Graham, Alan, Irving Kahns

Kahn Brothers Group

7.93%

989,274

$50.39

$49,847,023

+0.48% (+4,760)

+0.04%

Current price: $34.23 32.07% AVG reported hold price*: $50.39

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.